Dr. Michael Adam Feuerstein, MD

Dr. Feuerstein practices at Newyork-presbyterian Medical Group/westchester in Yorktown Heights, New York.

Dr. Feuerstein's NPI, 1427217041, was assigned on June 9, 2008. Dr. Feuerstein graduated from Albany Medical College in 2007. Dr. Feuerstein's New York license number on file is 2645051.

Dr. Feuerstein's primary practice is Newyork-presbyterian Medical Group/westchester, at 2649 Strang Blvd Suite 304 Suite 304, Yorktown Heights, NY 10598-2938. The practice phone is (646) 697-5663.

Dr. Feuerstein's primary practice is Newyork-presbyterian Medical Group/westchester in Yorktown Heights, New York. Dr. Feuerstein is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is NewYork-Presbyterian Medical Group Westchester. Dmand AI also links Dr. Feuerstein to 3 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Feuerstein practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Feuerstein's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Feuerstein is board certified in urology by the American Board of Urology. Dr. Feuerstein has a license on file in New York.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery and kidney stone disease among the conditions Dr. Feuerstein treats.

CMS data shows 575 Medicare services from Dr. Feuerstein across 10 procedure codes in 2024, for 275 Medicare patients. Medicare paid $49,367 for them. Every service was in an office.

CMS counts 275 Medicare patients who saw Dr. Feuerstein in 2024. The largest group is 75 to 84, with 132 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Feuerstein's median patient age at 65, with 16% women.

In 2024, Dr. Feuerstein wrote 506 Medicare Part D claims for 235 patients. 92% of them were for generic drugs. CMS names the drug for 395 of them, across 6 drugs with 11 or more claims each, at $28,915 in total drug cost. In 2023, CMS named 615 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Feuerstein for performance year 2024, reported through an alternative payment model (APM). Dr. Feuerstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Feuerstein as offering telehealth. CMS counts 12 procedures of prostate resection by Dr. Feuerstein, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 17 papers to Dr. Feuerstein, published from 2009 to 2019. 2014 was the busiest year, with 3. The most frequent topics are Kidney Neoplasms, Nephrectomy and Carcinoma, Renal Cell. Dr. Feuerstein has published most often in Eur Urol. Dr. Feuerstein's most frequent co-authors are Paul Russo, MD, James B. Bussel, MD and Jonathan Andrew Coleman, MD.

CMS Open Payments shows 53 general payments to Dr. Feuerstein from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Endo Pharmaceuticals Inc. paid the most, $321.

Dr. Feuerstein graduated from Albany Medical College in 2007. Dr. Feuerstein is a member of ACS, AUA and Society of Urologic Oncology.

Dr. Feuerstein is in network with 18 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.